Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.96B.
ENTERPRISE VALUE (EV)
$1.96B
LeMaitre Vascular, Inc.
Market Cap
$1.82B
Enterprise Value (EV)
$1.96B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| LeMaitre Vascular, Inc. (LMAT) | $1.82B | $1.96B |
| Novocure Ltd (NVCR)vs › | $1.82B | $1.96B |
| Novavax, Inc. (NVAX)vs › | $1.84B | $1.94B |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | $2.42B |
| Absci Corporation (ABSI)vs › | $1.79B | $1.69B |
| Azenta, Inc. (AZTA)vs › | $1.85B | $1.71B |
| Generate Biomedicines, Inc. (GENB)vs › | $1.79B | $1.72B |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.87B | $1.68B |
| Surgery Partners, Inc. (SGRY)vs › | $1.76B | $5.56B |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | $1.88B |
Market Cap
$1.82B
Total Debt
$168.65M
Cash
$28.24M
Enterprise Value
$1.96B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
